patient health News
-
Digital Technology Supercluster Member Spotlight
Did you miss the Digital Technology Supercluster Member Spotlight on Augurex? Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric digital health solutions: ...
-
UC Davis Health Welcomed Patients to New State-of-the-art Ernest E. Tschannen Eye Institute Building
UC Davis Health welcomed patients earlier this month to its new, state-of-the-art Ernest E. Tschannen Eye Institute Building, a new innovative facility dedicated to advancing world-class eyecare and offering hope for sight restoration through advanced technology, pioneering research and leading eyecare clinicians. Lombart is honored to have worked with this incredible clinic to make their vision ...
-
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, at 9:00 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website. About Thermo ...
-
Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST). Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations ...
-
Our Focus on Mission Driven Collective Innovation
Dyno empowers a diverse team of the best problem-solvers to drive cutting-edge science toward improving patient health. Our mission is to build the ideal capsid and solve the challenges of vivo gene delivery. We call ourselves AAViators and are engaged in Collective Innovation aswe aim to maximize our impact on patients through the development of groundbreaking technologies. AAViators ...
-
Cenofex Innovations Awarded $1.5M from NSW Medical Devices Fund
Cenofex Innovations has been awarded a $1.5M investment from the NSW 2018 Medical Devices Fund. Presented by the Brad Hazzard, the NSW Minister for Health, the NSW Medical Devices Fund is a competitive technology development and commercialisation program that aims to provide support to take local innovation to market. The fund is unique in its approach to provide substantial early funding ...
-
Amgen foundation and changemakers launch global online competition to empower patients for better outcomes
The Amgen Foundation is supporting an online competition with Ashoka"s Changemakers to find the best solutions that elevate patients" voices to improve health outcomes globally. The Patients| Choices| Empowerment competition is seeking solutions that tap the medical experience, knowledge, and wisdom of current and past patients, health care practitioners, advocates and other key stakeholders to ...
-
Defymed at the BIO International Convention in San Diego
Richard BOUAOUN our COO and Manuel Pires our BDO will attend the BIO International Convention held from June 13 to 16 in San Diego California (United States), the World’s largest gathering of biotechnology industry, along with industry-leading investor and partnering meetings held around the world. For the first time in three years the conference will be back fully in person and plan to ...
By Defymed
-
Defymed at the BIO International Convention in San Diego
Richard BOUAOUN our COO and Manuel Pires our BDO will attend the BIO International Convention held from June 13 to 16 in San Diego California (United States), the World’s largest gathering of biotechnology industry, along with industry-leading investor and partnering meetings held around the world. For the first time in three years the conference will be back fully in person and plan to ...
By Defymed
-
Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category
Kurin, Inc. has been named to Inc.’s inaugural Best in Business list in the Prosperous and Thriving category. Inc. created the Best in Business Awards to honor companies that have gone above and beyond to make a positive difference. The list, which can be found in the Winter issue of Inc. (on newsstands December 29, 2020), recognizes small- and medium-size privately held American ...
By Kurin, Inc.
-
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
WALNUT CREEK, Calif., Aug. 6, 2020 /PRNewswire/ -- Oncodisc, Inc. today announced that it is the recipient of a competitive National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant award. The grant award will be used to advance research and development work on the Oncodisc Remote Care Platform ("Oncodisc RCP") and the development of next-generation patient care ...
By Oncodisc
-
Forest Devices Announces That FDA Has Designated the AlphaStroke Technology a Breakthrough Device
Medical technology pioneer Forest Devices, Inc. (FDI), a medical device company focused on identifying patients with large vessel occlusive (LVO) strokes in the prehospital environment, today announced that the U.S. Food and Drug Administration (FDA) has designated its AlphaStroke technology as a Breakthrough Device. “We are thrilled to work closely with the FDA to accelerate the ...
-
Effects of prosthetic limb prescription on 3-year mortality among Veterans with lower-limb amputation
Method: Retrospective observational study on 4,578 Veterans hospitalized for LLA and discharged 2003- 2004, looking at time to all-cause mortality from the amputation surgical date up to the 3 yr anniversary. Results: 1,300 (28.4%) persons received a prescription for a prosthetic limb within 1 yr after the surgical amputation. About 46% (n = 2,086) of all Veterans w LLA died within 3 yr of the ...
-
Quadrant Biosciences Receives Breakthrough Device Designation for Novel Autism Saliva Test
Quadrant Biosciences Inc., a developer of novel molecular diagnostic tools, has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its innovative Clarifi ASD® autism saliva test. Clarifi ASD is indicated for use in assessing the likelihood that a child has autism spectrum disorder (ASD) based on ...
-
Kurin, Inc. announces results on Kurin efficacy from Oishei Children`s Hospital with zero blood culture
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that Oishei Children’s Hospital, a member of Kaleida Health, in Buffalo, NY, presented their findings on their use of Kurin at the recent Association for Professionals in Infection Control conference. This is the first study of Kurin, a passive low-volume blood culture ...
By Kurin, Inc.
-
Showcase
New device offers a mouthful of data for chronic diseases
Aidar Health, formerly known as Multisensor Diagnostics, has developed a portable hand-held device that allows patients to measure and track vital signs in a matter of seconds. Roughly the size of an iPhone, MouthLab consists of a hand unit and a mouthpiece that fits between the teeth and lips. The mouthpiece uses special sensors to gather information from breathing patterns, saliva and blood ...
By Aidar Health
-
Heritage Provider Network, Regal Medical Group and Dr. Richard Merkin come to the aid of Pakistani flood victims
Dr. Richard Merkin, President and CEO of Heritage Provider Network is pleased to announce that the Regal Medical Group, part of the HPN family, has coordinated a fundraising effort through their employees for the flood victims in Pakistan. The monies raised will be donated through the Red Cross for the immediate relief to those affected in Pakistan. According to the UN, the floods have disrupted ...
-
New Bone Data Comparing ImpediMed’s SOZO to DXA in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conference
ImpediMed Limited (ASX.IPD), a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health is pleased to announce an abstract comparing concurrent measures using ImpediMed’s SOZO® Digital Health Platform and dual x-ray absorptiometry (DXA) for assessing in bone mineral content in cancer patients was accepted for ...
-
Our Partnership with Cerba HealthCare
The Cerba HealthCare Group and METAFORA biosystems are to cooperate in the deployment of METAFORA proprietary technology in the field of metabolomics for diagnostics purposes. The technological platform developed by METAFORA enables the evaluation of cells’ energy needs in connection with patients’ health. “The investigation into altered metabolic functions for the ...
-
Digitsole Pro® is FDA Registered Class II - Innovative AI-Based Solution for Clinical Assessment of Mobility Disorders
Digitsole, a leader in the digital health space bringing together digital mobility biomarkers and biomechanical data with clinical expertise, has received Class II medical device registration with the U.S. Food and Drug Administration (FDA) for its Digitsole Pro® smart insoles. Digitsole Pro®, recently launched in the United States, is a solution, developed with, and for ...
By Digitsole
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you